Abstral (Fentanyl)
fentanyl 300 microgram sublingual tablet, 10 · SUBLINGUAL · PBS code 10606F
AUTHORITY_REQUIREDWhat it costs
AU$58.48 PBS-determined price per 10 units
Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.
- • First listed on the PBS: 2016-02-01.
- • Repeats: 0.
- • PBS program: PL.
Eligibility criteria for subsidised access
The following is the government's own wording from the PBS Schedule, shown unchanged.
Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1
Breakthrough pain
Initial treatment for dose titration
Patient must have cancer; AND
Patient must have pain directly attributable to cancer; AND
Patient must be assessed as receiving adequate management of their persistent pain with opioids; AND
Patient must have previously experienced inadequate pain relief following adequate doses of short acting opioids for the treatment of breakthrough pain; or
The treatment must be used as short acting opioids are considered clinically inappropriate; or
Patient must have previously experienced adverse effects following the use of short acting opioids for breakthrough pain; AND
Patient must be undergoing palliative care.
Sponsor: A.Menarini Australia Pty Limited ABN 62 116 935 758
Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.
Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.